IFN-α is used to treat chronic viral infections: it suppresses CYP3A4 expression in human hepatoma cells (43) and alter the expression of constitutive and inducible CYP3A genes in well-differentiated male rat hepatocytes in culture (44). The gene discussed is CYP3A4; the disease is hepatocellular carcinoma.